Press releases

Full text versions of press releases are only available in Swedish

2021-08-17
ONCOZENGE AB INTERIM REPORT FOR JANUARY - JUNE 2021
Read More

2021-08-10
ONCOZENGE AB INTERIM REPORT FOR JANUARY - JUNE 2021 TO BE PUBLISHED ON AUGUST 17 - INVITATION TO TELECONFERENCE
Read More

2021-05-25
BULLETIN FROM ONCOZENGE AGM ON MAY 25, 2021
Read More

2021-05-18
ONCOZENGE AB INTERIM REPORT JANUARY-MARCH 2021
Read More

2021-04-26
NOTICE OF ANNUAL GENERAL MEETING OF ONCOZENGE AB (PUBL)
Read More

2021-04-12
ONCOZENGE APPOINTS DR. MARKUS JERLING TO CHIEF MEDICAL OFFICER
Read More

2021-03-18
LAST DAY FOR TRADING IN BTA
Read More

2021-03-09
ONCOZENGE RIGHTS ISSUE HEAVILY OVERSUBSCRIBED AND NO ISSUE GUARANTEES HAVE BEEN EXERCISED
Read More

2021-02-19
THE SUBSCRIPTION PERIOD FOR ONCOZENGE´S RIGHTS ISSUE BEGINS TODAY
Read More

2021-02-15
THE LAST DAY FOR TRADING IN THE RIGHT TO RECEIVE SUBSCRIPTION RIGHTS IS TODAY, FEBRUARY 15, 2021
Read More

2021-02-12
TRADING IN ONCOZENGE´S SHARE ON THE NASDAQ FIRST NORTH GROWTH MARKET BEGINS TODAY
Read More

2021-02-10
ONCOZENGE HAS BEEN APPROVED FOR LISTING ON NASDAQ FIRST NORTH GROWTH MARKET
Read More

2021-02-08
CORRECTION REGARDING ISIN CODE FOR THE SHARE IN THE PROSPECTUS
Read More

2021-02-08
ONCOZENGE HAS OBTAINED A CONDITIONAL APPROVAL FOR LISTING ON NASDAQ FIRST NORTH GROWTH MARKET AND PUBLISHES PROSPECTUS
Read More

2021-01-29
ANNOUNCEMENT OF TERMS FOR THE FULLY GUARANTEED RIGHTS ISSUE IN ONCOZENGE, TIMETABLE FOR THE LISTING AND RECORD DATE FOR LEX ASEA
Read More

2021-01-28
ONCOZENGE ANNUAL REPORT 2020
Read More

2021-01-07
ONCOZENGE ANNOUNCES ISSUE OF EUROPEAN PATENT RELATED TO BUPIZENGE®
Read more

2020-12-16
ONCOZENGE EXPANDS THE BOARD WITH HILDE FURBERG
Read more

2020-11-30
MOBERG PHARMA OBTAINS POSITIVE DECISION FROM THE SWEDISH TAX AGENCY REGARDING THE LEX ASEA DISTRIBUTION OF THE SHARES IN ONCOZENGE
Read more

2020-11-23
INVITATION TO MARKET UPDATE IN MOBERG PHARMA ON NOVEMBER 25TH
Read more

2020-11-16
ONCOZENGE SECURES APPROXIMATELY SEK 70 MILLION IN FINANCING AHEAD OF SPIN-OFF AND SEPARATE LISTING
Read more

2020-11-06
MOBERG PHARMA INTENDS TO DISTRIBUTE AND SEPARATELY LIST BUPIZENGE[®] (BUPI)
Read more